Vymada 100mg Tablet

Vymada 100 mg Tablet is a prescription medicine used to manage chronic heart failure with reduced ejection fraction (HFrEF) in adults. It combines Sacubitril, a neprilysin inhibitor, with Valsartan, an angiotensin II receptor blocker (ARB), to improve the heart's ability to pump blood efficiently. This combination helps reduce fluid buildup, relax blood vessels, lower blood pressure, and decrease the workload on the heart. Regular use reduces the risk of hospitalization due to heart failure and cardiovascular death, while relieving symptoms such as shortness of breath, tiredness, and swelling of the legs or ankles. Vymada is prescribed as part of a comprehensive heart failure treatment plan that includes lifestyle modifications such as a low-salt diet, regular physical activity as advised, weight management, and routine medical monitoring. Consistent treatment helps improve daily functioning, exercise capacity, and long-term heart health.

Vymada 100 mg Tablet combines Sacubitril 49 mg and Valsartan 51 mg to provide effective long-term management of chronic heart failure with reduced ejection fraction. Sacubitril inhibits the enzyme neprilysin, increasing beneficial natriuretic peptides that help relax blood vessels, remove excess sodium and water, reduce fluid overload, and lower pressure on the heart. Valsartan, an angiotensin II receptor blocker, blocks the harmful effects of angiotensin II by preventing blood vessel constriction and reducing blood pressure and fluid retention.

Together, these medicines improve cardiac output, decrease symptoms such as breathlessness, fatigue, and swelling, and significantly reduce the risk of hospitalization and cardiovascular death. Regular treatment slows the progression of heart failure, improves exercise capacity, and supports better daily functioning. Combined with healthy lifestyle measures such as reducing salt intake, maintaining a healthy weight, taking medicines consistently, and attending regular medical check-ups, Vymada helps improve long-term cardiovascular health and overall quality of life.

Precaution

• Use only under medical supervision.
• Do not use during pregnancy, as it may seriously harm the unborn baby.
• Inform your doctor if you have kidney disease, liver disease, or low blood pressure.
• Avoid potassium supplements or potassium-containing salt substitutes unless advised.
• Regular monitoring of blood pressure, kidney function, and potassium levels may be required.
• A 36-hour washout period is required between stopping an ACE inhibitor and starting Vymada to reduce the risk of angioedema.

Storage

• Store below 30°C.
• Keep in a cool, dry place.
• Protect from moisture and direct sunlight.
• Store in the original packaging.
• Keep out of reach of children.